Renalytix plc American Depositary Shares
RNLX
RNLX was delisted on the 7th of October, 2024.
31 hedge funds and large institutions have $13.9M invested in Renalytix plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 35 → 31 (-4)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
68% less capital invested
Capital invested by funds: $43.8M → $13.9M (-$29.9M)
97% less call options, than puts
Call options by funds: $1K | Put options by funds: $37K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$2.69M |
| 2 |
PCM
Philosophy Capital Management
Alamo,
California
|
+$636K |
| 3 |
Lazard Asset Management
New York
|
+$411K |
| 4 |
JP Morgan Chase
New York
|
+$208K |
| 5 |
Morgan Stanley
New York
|
+$198K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.01M |
| 2 |
Two Sigma Investments
New York
|
-$373K |
| 3 |
Millennium Management
New York
|
-$323K |
| 4 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$302K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$202K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Rockefeller Capital Management
New York
| $8K | -$8.84K | -1,859 | -34% |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $6K | +$4.28K | +900 | +67% |
|
28
Citigroup
New York
| $6K | +$12.5K | +2,630 | +13,150% |
|
29
UBS Group
Zurich,
Switzerland
| $1K | -$476 | -100 | -17% |
|
30
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
VVP
31
Venture Visionary Partners
Sylvania,
Ohio
| $330 | +$642 | +135 | New |
|
|
32
Two Sigma Investments
New York
| – | -$373K | -53,938 | Closed |
|
33
Legal & General Group
London,
United Kingdom
| – | -$133K | -19,279 | Closed |
|
|
SGM
34
Skye Global Management
West Palm Beach,
Florida
| – | -$119K | -17,200 | Closed |
|
35
Two Sigma Advisers
New York
| – | -$76K | -11,000 | Closed |
|
|
TFA
36
Toth Financial Advisory
Leesburg,
Virginia
| – | -$1K | -100 | Closed |
|
RNLX Hedge Fund Activity: Q2 2022 in Review
31 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Renalytix plc American Depositary Shares (RNLX) for Q2 2022, worth a combined $13.9M — down 68% from $43.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RNLX and 2 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 10 added.
The largest buyer was GW&K Investment Management, opening a new position worth an estimated $2.69M. The largest seller was Gilder Gagnon Howe & Co, cutting an estimated $6.01M.
- 31 institutional investors held Renalytix plc American Depositary Shares (RNLX) as of Q2 2022, down from 35 in Q1 2022.
- Funds reported $13.9M of Renalytix plc American Depositary Shares stock for Q2 2022, down 68% quarter-over-quarter.
- 2 funds opened new Renalytix plc American Depositary Shares positions in Q2 2022 and 6 closed out, a net change of -4 holders.
- The largest Renalytix plc American Depositary Shares buyer in Q2 2022 was GW&K Investment Management, an estimated $2.69M added.
- The largest Renalytix plc American Depositary Shares seller in Q2 2022 was Gilder Gagnon Howe & Co, an estimated $6.01M sold.
Based on aggregated 13F filings for Q2 2022.